Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumor: being younger and getting less benefit from adjuvant tamoxifen treatment

被引：0
|
作者：
Yu, K. [1 ]
Di, G. [1 ]
Wu, J. [1 ]
Lu, J. [1 ]
Shen, K. [1 ]
Shen, Z. [1 ]
Shao, Z. [1 ]
机构：
[1] Fudan Univ, Canc Hosp Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70759-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [41] A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer
    Yu Fan
    Xiaorong Zhong
    Yu Wang
    Zhu Wang
    Ting Luo
    Yanping Wang
    Hong Zheng
    Breast Cancer Research and Treatment, 2023, 200 : 171 - 182
  • [42] Circulating sphingomyelins on estrogen receptor-positive and estrogen receptor-negative breast cancer-specific survival
    Adams, Charleen D.
    BREAST CANCER MANAGEMENT, 2020, 9 (03)
  • [43] Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells
    Kim, Kyung-Ho
    Kim, Ji-Yun
    Kwak, Jong-Hwan
    Pyo, Suhkneung
    PHYTOMEDICINE, 2015, 22 (09) : 820 - 828
  • [44] Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast Cancer
    Kim, Chungyeul
    Tang, Gong
    Pogue-Geile, Katherine L.
    Costantino, Joseph P.
    Baehner, Frederick L.
    Baker, Joffre
    Cronin, Maureen T.
    Watson, Drew
    Shak, Steven
    Bohn, Olga L.
    Fumagalli, Debora
    Taniyama, Yusuke
    Lee, Ahwon
    Reilly, Megan L.
    Vogel, Victor G.
    McCaskill-Stevens, Worta
    Ford, Leslie G.
    Geyer, Charles E., Jr.
    Wickerham, D. Lawrence
    Wolmark, Norman
    Paik, Soonmyung
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4160 - 4167
  • [45] The rate of estrogen receptor-conversion associated with tumor progression in estrogen receptor-positive breast cancer patients following adjuvant Tamoxifen administration
    Djahansouzi, Sirus
    Hanstein, Bettina
    Rein, Daniel
    Clees, Michel
    Rath, Werner
    CANCER REPORTS, 2022, 5 (01)
  • [46] Immunohistochemical and clinicopathologic features of estrogen receptor-negative, progesterone receptor-positive, HER-2 negative breast carcinomas
    De Nardi, Rosana Pellin
    Uchoa, Diego
    Remonatto, Gabriela
    Biazus, Jorge Villanova
    Damin, Andrea Pires
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (02): : 265 - 270
  • [47] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Moon, Yong Wha
    Park, Seho
    Sohn, Joo Hyuk
    Kang, Dae Ryong
    Koo, Ja Seung
    Park, Hyung Seok
    Chung, Hyun Cheol
    Park, Byeong-Woo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1123 - 1130
  • [48] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Yong Wha Moon
    Seho Park
    Joo Hyuk Sohn
    Dae Ryong Kang
    Ja Seung Koo
    Hyung Seok Park
    Hyun Cheol Chung
    Byeong-Woo Park
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1123 - 1130
  • [49] Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
    Niemeier, Leo A.
    Dabbs, David J.
    Beriwal, Sushil
    Striebel, Joan M.
    Bhargava, Rohit
    MODERN PATHOLOGY, 2010, 23 (02) : 205 - 212
  • [50] Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
    Gucalp, Ayca
    Tolaney, Sara
    Isakoff, Steven J.
    Ingle, James N.
    Liu, Minetta C.
    Carey, Lisa A.
    Blackwell, Kimberly
    Rugo, Hope
    Nabell, Lisle
    Forero, Andres
    Stearns, Vered
    Doane, Ashley S.
    Danso, Michael
    Moynahan, Mary Ellen
    Momen, Lamia F.
    Gonzalez, Joseph M.
    Akhtar, Arooj
    Giri, Dilip D.
    Patil, Sujata
    Feigin, Kimberly N.
    Hudis, Clifford A.
    Traina, Tiffany A.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5505 - 5512
12345